Fresh Farms E-Liquid Confirms September 6 Submission of Highly-Anticipated PMTA
September 15, 2020 10:04 ET
|
Fresh Farms E-Liquid, LLC
FOUNTAIN VALLEY, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- Fresh Farms E-Liquid, LLC, a global leader in both the vapor and CBD industries, confirmed its September 6, 2020...
Open Book Extracts Acquires Chilmark Labs to Commercialize Rare Cannabinoids and Pioneer Scientific Research and Technologies for the CBD Industry
June 15, 2020 07:00 ET
|
Open Book Extracts
ROXBORO, N.C., June 15, 2020 (GLOBE NEWSWIRE) -- Open Book Extracts, one of the leading vertically integrated, cGMP certified processors of high-quality cannabinoid products, is pleased to announce...
Acquired Sales Corp. Signs Definitive Merger Agreement to Acquire 100% of Rapidly Growing Lifted Liquids
January 08, 2020 07:00 ET
|
Acquired Sales Corp.
LAKE FOREST, Ill., Jan. 08, 2020 (GLOBE NEWSWIRE) -- Acquired Sales Corp. (OTC Pink: AQSP) today announced that it has signed a definitive merger agreement to acquire 100% of rapidly growing and...
MCTC Expands R&D Program to Include Producing Polymeric Nanoparticles of Valuable, Hard-to-Obtain Cannabinoids
November 20, 2019 07:30 ET
|
MCTC Holdings Inc. (d/b/a Cannabis Global)
LOS ANGELES, Nov. 20, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – MCTC Holdings Inc. (OTC: MCTC) today announces an expanded R&D program designed to produce polymeric nanoparticles of cannabinol...
Independent Valuation of U.S. Patent Number 9,763,991 for Cannabinol (CBN) Initiated as Cannabis Science Negotiates Licensing and Marketing Deals in Canada and the USA to Develop and Sell CBN Products Utilizing the Company’s Patent
April 15, 2019 07:33 ET
|
Cannabis Science, Inc.
Cannabis Science’ CBN Patent is for the Treatment of Neurological Conditions, Including Sleep Deprivation, Anxiety, PTSD, and More IRVINE, CA, April 15, 2019 (GLOBE NEWSWIRE) -- via...
Cannabis Science Set to Integrate Its Sponsored Research In Nigeria to Include Its U.S. Patent Number 9,763,991 for Compositions of Cannabinol (CBN) for Treatment of Various Neurological Conditions
February 25, 2019 07:28 ET
|
Cannabis Science, Inc.
IRVINE, CA, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Pre-Clinical Work and Animal Studies Underway, and Protocols for Clinical Studies Under Development via NEWMEDIAWIRE -- Cannabis Science, Inc....
Axim® Biotechnologies Announces Positive Results From Stability And Dissolution Tests On Medchew Rx Showing Greater Than 90% Availability
August 07, 2018 08:55 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Aug. 07, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC: AXIM), a world leader in cannabinoid research and development, today announced positive results from...
Relevium Creates Biocannabix Subsidiary and Targets Legal Cannabis Business
April 19, 2018 10:14 ET
|
Relevium Technologies Inc
MONTREAL, April 19, 2018 (GLOBE NEWSWIRE) -- Relevium Technologies Inc. (TSX VENTURE:RLV) (OTCQB:RLLVF) (FRANKFURT:6BX) (the “Company” or “Relevium”), is pleased to announce the creation of...
Octavia Wellness Launches “Healing without the High” Cannabis Starter Kit Tailored for Seniors
November 28, 2017 16:30 ET
|
Octavia Wellness
San Francisco, California, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Octavia Wellness, the leading provider of custom cannabis solutions for seniors, introduces a Cannabis Starter Kit developed specifically...
AXIM Biotechnologies, Inc. Announces Cosmetics Division
February 19, 2015 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Feb. 19, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM), an industry leader in cannabinoid research and industrial hemp product development, is proud to announce that it has...